Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
12.01%
operating margin TTM
16.81%
revenue TTM
2.88 Billion
revenue per share TTM
25.97$
valuation ratios | |
|---|---|
| pe ratio | 10.75 |
| peg ratio | 0.87 |
| price to book ratio | 1.66 |
| price to sales ratio | 1.29 |
| enterprise value multiple | 3.39 |
| price fair value | 1.66 |
profitability ratios | |
|---|---|
| gross profit margin | 41.66% |
| operating profit margin | 16.81% |
| pretax profit margin | 15.5% |
| net profit margin | 12.01% |
| return on assets | 7.08% |
| return on equity | 15.65% |
| return on capital employed | 13.32% |
liquidity ratios | |
|---|---|
| current ratio | 1.82 |
| quick ratio | 1.06 |
| cash ratio | 0.23 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 207.00 |
| operating cycle | 324.82 |
| days of payables outstanding | 133.82 |
| cash conversion cycle | 191.00 |
| receivables turnover | 3.10 |
| payables turnover | 2.73 |
| inventory turnover | 1.76 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.29 |
| debt equity ratio | 0.64 |
| long term debt to capitalization | 0.36 |
| total debt to capitalization | 0.39 |
| interest coverage | 5.30 |
| cash flow to debt ratio | 0.24 |
cash flow ratios | |
|---|---|
| free cash flow per share | 1.77 |
| cash per share | 3.22 |
| operating cash flow per share | 3.55 |
| free cash flow operating cash flow ratio | 0.50 |
| cash flow coverage ratios | 0.24 |
| short term coverage ratios | 3.43 |
| capital expenditure coverage ratio | 2.00 |
Frequently Asked Questions
When was the last time Hikma Pharmaceuticals PLC (PNK:HKMPY) reported earnings?
Hikma Pharmaceuticals PLC (HKMPY) published its most recent earnings results on 30-06-2025.
What is Hikma Pharmaceuticals PLC's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Hikma Pharmaceuticals PLC (PNK:HKMPY)'s trailing twelve months ROE is 15.65%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Hikma Pharmaceuticals PLC (HKMPY) currently has a ROA of 7.08%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did HKMPY's net profit margin stand at?
HKMPY reported a profit margin of 12.01% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is HKMPY's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.82 in the most recent quarter. The quick ratio stood at 1.06, with a Debt/Eq ratio of 0.64.